Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Long-Term Clinical Follow-Up of Children Enrolled in Stannsoporfin Clinical Trial Protocol No. 64,185-06-2(W)(WS)(ISNHP)

NCT02685189 is registered in ClinicalTrials.gov with InfaCare Pharmaceuticals Corporation, a Mallinckrodt Company as lead sponsor.

NCT NCT02685189
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02685189 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Long-Term Clinical Follow-Up of Children Enrolled in Stannsoporfin Clinical Trial Protocol No. 64,185-06-2(W)(WS)(ISNHP)
Lead sponsor
InfaCare Pharmaceuticals Corporation, a Mallinckrodt Company
Phase
Observational
Overall status
Terminated
Start date
July 31, 2006
Completion date
May 10, 2016
Enrollment
55 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

hyperbilirubinemia